Ӳ֬֬Ҵ-Ҷ-)DSPE-PEG-Fabof C225 mAb(cetuximab)
l(f)r(sh)g2022-03-30 DSPE-PEG-Fabof C225 mAb(cetuximab) PEG:2000;3000;5000 :Fabof C225 mAb(cetuximab)
؛̖(ho) | Ҏ(gu) | (sh) | r(ji) |
---|---|---|---|
Q-0056829 | 100mg |
1
|
ԃr(ji) |
Q-0056829 | 250mg |
1
|
ԃr(ji) |
Q-0056829 | 500mg |
1
|
ԃr(ji) |
Q-0056829 | 1g |
1
|
ԃr(ji) |
Q-0056829 | 5g |
1
|
ԃr(ji) |
ӆُ(gu)/bԃ
N۽(jng)

I(y)(w)ЙC(j) | Ӳ | ٴ | | {a(chn)Ʒ
ԓa(chn)Ʒa(chn)ۺ}Ո(qng)(lin)ϵ҂
a(chn)ƷB
Ӳ֬֬Ҵ-Ҷ-)
DSPE-PEG-Fab’of C225 mAb(cetuximab)
DSPE-PEG-Fab’of C225 mAb(cetuximab)
PEG:2000;3000;5000
:Fab’of C225 mAb(cetuximab)
P(gun)a(chn)Ʒ
m-PEG3-Sulfone-PEG2-OH CAS:1919045-00-3 | pgӹٷ |
m-PEG3-Sulfone-PEG3-azide CAS:1895922-76-5 | pgӹٷ |
m-PEG3-Sulfone-PEG3-acid CAS:1919045-04-7 | pgӹٷ |
Azido-PEG3-Sulfone-PEG4-t-butyl ester CAS:2055023-76-0 | pgӹٷ |
Azide-PEG3-Sulfone-PEG3-azide CAS:2055024-45-6 | pgӹٷ |
Azido-PEG3-Sulfone-PEG4-acid CAS:2055024-42-3 | pgӹٷ |
Acid-PEG4-Sulfone-PEG4-acid CAS:2055024-37-6 | pgӹٷ |
t-Butoxycarbonyl-PEG4-S-PEG4-t-butyl ester | pgӹٷ |
Propargyl-PEG4-S-PEG4-t-butyl ester CAS:2055041-18-2 | pgӹٷ |
Propargyl-PEG4-S-PEG4-propargyl CAS:2055041-17-1 | pgӹٷ |
Propargyl-PEG4-S-PEG4-acid CAS:2055041-20-6 | pgӹٷ |
m-PEG3-S-PEG3-t-butyl ester CAS:2055040-96-3 | pgӹٷ |
a(chn)أ
ȣ99%
;Hڿ
YρС2022.03.29
(sh)Ϣ | |
---|---|
^B(ti) | wĩ |
|(zh)ָ(bio) | 95%+ |
ܽl | ЙC(j)܄/ˮ |
CAS̖(ho) | N/A |
N/A | |
(ch)l | -20ܹⱣ |
(ch)r(sh)g | 1 |
\(yn)ݔl | Ҝ2 |
a(chn)Sң | pgӹٷƼ˾ |
P(gun)a(chn)Ʒ
-
DSPE-PEG-FA һN͵İ֬-ҶPEGPEGĩ~ᣨFolic Acid, FAԓϽY(ji)DSPE֬PEGL(zhng)HˮԾۺFAСӰwă(yu)c(din)߂õHˮԡԺ[
-
ӢCy5-PEG-NH? s2000 Da CY5-PEG2K-NH2Cy5(bio)ӛPEGľҶA(ch)һ˘(bio)ӛCy5ɹȾһ˱CNH?܈F(tun)Cy5һNtɹȾl(f)䲨L(zhng)s670 nmеͱ(qing)̖(ho)ⷀ(wn)c(din)
-
l(f)r(sh)g2022-03-30 DSPE-PEG-Fabof matuzumab or C225Ӳ֬֬Ҵ-Ҷ-) PEG:2000;3000;5000 DSPE-PEG-Fabof matuzumab or C225
-
l(f)r(sh)g2022-03-30Ӳ֬֬Ҵ-Ҷ- PEG:2000;3000;5000 :mAb 2C5 DSPE-PEG-mAb 2C5